113. Sickle Cell Disease, Sickle Cell Trait and Other Hemoglobinopathies, Excluding Thalassemias: Basic and Translational: Poster I

Plasma Proteome Profiling of Sickle Cell Patients Reveals Activation of Inflammatory Pathways during Steady State and Vaso-Occlusive Crisis

Effect of the Oral LSD1 Inhibitor Ory-1001 on F-Retics in Baboons (Papio anubis)

Targeting p38 Mitogen Activated Protein Kinase to Ameliorate Pain in SCD

Single Cell Analysis and Functional Features of Circulating CD34+ Cells from Patients with Sickle Cell Anaemia Unveil a Defect in the Myeloid Lineage

miRNA-369-5p within Small Extracellular Vesicles Correlates with Acute Chest Syndrome in Patients with Sickle Cell Disease

Voxelotor and Red Blood Cell Pyruvate Kinase Activator Affect Clot Strength in Sickle Cell Disease

Red Blood Cell Pyruvate Kinase Properties in Sickle Cell Disease – of Mice and Men

Impact of Vaso-Occlusive Crises on the Transcriptomes of Patients with Sickle Cell Disease

Iron Restricted Erythropoiesis Under Hepcidin Mimetic Treatment (PN23114) Improved Disease Parameters in a Mouse Model for Sickle Cell Disease

Assessing Real-Time Sickling Kinetics in Individual Cells from Erythrocyte Populations of Subjects with Different HbA, HbS and HbF Percentages

The Proteomic Signature of Extracellular Vesicles from Sickle Cell Anemia Patients Provides Insights into Their Possible Role in the Pathophysiology o

Circulating NETs Promote Platelet-TLR9 Dependent Acute Chest Syndrome in Sickle Cell Disease

Dual P-Selectin and Complement Inhibition with Subcutaneous IHP-102 Treatment Potently Reduces Lung Vaso-Occlusion in Sickle Cell Disease Mice